In a move to cut production costs, Apple plans to reuse iPhone 13 OLED panels for the upcoming iPhone SE 4, insiders reveal.
Reusing iPhone 13 OLED Panels
There have been rumors that Apple's future budget iPhone SE 4 will employ the same manufacturing technique as the iPhone 16's rear panel. However, this does not guarantee that the handset will include the latest hardware.
Apparently, in an effort to cut costs, the display will be several generations old, reusing the OLED panel from the iPhone 13, WCCFTECH reports.
Reportedly, Samsung and BOE were in a pricing war, and the Chinese display producer came out on top after accepting Apple's $25 offer per OLED, a sum that Samsung turned down because of its slim profit margins.
LG and BOE to Supply Panels
Nevertheless, according to The Elec, LG will join BOE as an additional supplier for the displays of the iPhone SE 4. LG is anticipated to provide display modules for older iPhone models.
Although the low-cost model's official launch is likely to occur in early 2025, earlier reports indicated that mass production will begin in October.
The article claims that Apple would decrease production costs by lowering display standards and reusing the OLED panels from the iPhone 13, although it does not specify how much the iPhone SE 4 will cost.
SE 4 Not a 'Home Run' Product
This could lead to a decrease in total brightness and less accurate color production on the iPhone SE 4 screen, in addition to the lack of ProMotion compatibility, all of which could negatively impact the user experience.
Considering that Apple never meant for the iPhone SE 4 to be a "home run" product, the reported 20 million OLED handsets supplied by BOE is a reasonable number. It is highly improbable that the European display maker Tianma will be included to the supply chain for the iPhone SE 4, despite its efforts to win over Apple.


OpenAI Expands Globally with First Overseas AI Lab in Singapore
SoftBank Shares Surge as OpenAI IPO Buzz and SB Energy Filing Boost AI Optimism
OpenAI Eyes IPO Filing as Early as This Week Amid Rising AI Competition
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
Samsung Faces Major Strike Threat as Union Restarts Pay Talks
Pentagon Expands AI Model Testing as It Seeks Alternatives to Anthropic’s Claude
Intuit Raises Full-Year Forecast After Strong Q3 Earnings Despite Stock Drop
TrumpRx Expands Discount Drug Access With 600 Generic Medications
TSMC Stake Sale Sends Vanguard Semiconductor Shares Lower
SpaceX Eyes AI Computing Expansion Ahead of Historic IPO
X Corp Loses Legal Battle Over Australia Child Safety Fine
Goldman Sachs to Pay $500M in 1MDB Shareholder Fraud Settlement
Google, Blackstone Launch $5B AI Cloud Venture to Challenge Nvidia and CoreWeave
Texas Sues Meta Over WhatsApp Encryption Claims
China vs U.S. AI Race Shifts Toward Robotics and Manufacturing Power in 2026 



